Literature DB >> 29066638

Birt-Hogg-Dubé syndrome: awareness is important!

Rui Caetano Oliveira1, Edgar Tavares1, Vítor Sousa2, Arnaldo Figueiredo1.   

Abstract

Birt-Hogg-Dubé (BHD) is a rare syndrome of inherited renal cell carcinomas, characterised by cutaneous lesions and pulmonary cysts and pneumothorax in a vast majority of the patients. Awareness of this syndrome is important in order to refer patients for genetic counselling and personalised follow-up as soon as possible. We describe a case of a 30-year-old female referred to our institution due to incidental discovery of solid bilateral renal masses. Renal biopsies were consistent with chromophobe tumour, and bilateral nephrectomy was performed. Gross examination revealed deformed kidneys with 28 brown and solid lesions, size variable between 0.1 and 6 cm, histologically corresponding to renal cell carcinomas, chromophobe type. Genetic test was required that showed a c.573delGAinsT frameshift mutation in heterozigosity at the folliculin gene, consistent with BHD diagnosis. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  oncology; pathology; urological cancer; urology

Mesh:

Substances:

Year:  2017        PMID: 29066638      PMCID: PMC5665185          DOI: 10.1136/bcr-2017-221022

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Birt-Hogg-Dubé syndrome: identifying patients at risk of renal cell carcinoma, pulmonary cysts and pneumothoraces.

Authors:  Stephanie Menzies; Aurelie Fabre; Aoife Lally
Journal:  BMJ Case Rep       Date:  2016-01-13

Review 2.  Inherited renal carcinomas.

Authors:  Akira Kawashima; Scott W Young; Naoki Takahashi; Bernard F King; Thomas D Atwell
Journal:  Abdom Radiol (NY)       Date:  2016-06

3.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  B Escudier; C Porta; M Schmidinger; N Rioux-Leclercq; A Bex; V Khoo; V Gruenvald; A Horwich
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

Review 4.  Birt-Hogg-Dubé syndrome: diagnosis and management.

Authors:  Fred H Menko; Maurice A M van Steensel; Sophie Giraud; Lennart Friis-Hansen; Stéphane Richard; Silvana Ungari; Magnus Nordenskjöld; Thomas Vo Hansen; John Solly; Eamonn R Maher
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

5.  The Birt-Hogg-Dubé cancer predisposition syndrome: Current challenges.

Authors:  Patrick R Benusiglio
Journal:  Intractable Rare Dis Res       Date:  2015-08

Review 6.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

7.  Birt-Hogg-Dubé syndrome.

Authors:  André Lencastre; Pedro Ponte; Margarida Apetato; Luis Nunes; Sara Lestre
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

Review 8.  Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.

Authors:  Hisashi Hasumi; Masaya Baba; Yukiko Hasumi; Mitsuko Furuya; Masahiro Yao
Journal:  Int J Urol       Date:  2015-11-25       Impact factor: 3.369

9.  Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.

Authors:  Mitsuko Furuya; Masahiro Yao; Reiko Tanaka; Yoji Nagashima; Naoto Kuroda; Hisashi Hasumi; Masaya Baba; Jun Matsushima; Fumio Nomura; Yukio Nakatani
Journal:  Clin Genet       Date:  2016-06-30       Impact factor: 4.438

10.  Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.

Authors:  A C Houweling; L M Gijezen; M A Jonker; M B A van Doorn; R A Oldenburg; K Y van Spaendonck-Zwarts; E M Leter; T A van Os; N C T van Grieken; E H Jaspars; M M de Jong; E M H F Bongers; P C Johannesma; P E Postmus; R J A van Moorselaar; J-Htm van Waesberghe; T M Starink; M A M van Steensel; J J P Gille; F H Menko
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.